快速反应与心脏骤停团队:103家美国医院的描述性分析
该研究为描述性横断面网络调查,于2018年6月至12月通过个人与专业联系识别参与成人快速反应系统的临床医生,分发114份问卷,回收109份(96%),排除6份重复后最终分析103家医院(来自30个州)的103份问卷。76%为学术医院,30%为大型医院(>750张住院床位),58%拥有大型ICU(>50张ICU床位)。研究发现快速反应系统传入支与传出支的结构和功能差异很大,多数医院同时设有快速反应团队和心脏骤停团队,大多数快速反应团队包含一名提供者、一名重症监护护士和一名呼吸治疗师。在有内科、麻醉科、急诊科或重症医学科培训项目的医院中,45%的快速反应团队和75%的心脏骤停团队由受训人员主导,主治医师在场情况不一致。院内心脏骤停后目标温度管理和冠状动脉导管插入术广泛使用,但适应证差异很大。
要点
- 在103家美国医院中,多数同时设有快速反应团队和心脏骤停团队,但系统结构与功能差异很大。
- 在有内科、麻醉科、急诊科或重症医学科培训项目的医院,45%快速反应团队和75%心脏骤停团队由受训人员主导,主治医师在场不一致。
- 大多数快速反应团队包含一名提供者、一名重症监护护士和一名呼吸治疗师。
- 院内心脏骤停后目标温度管理和冠状动脉导管插入术广泛使用,但适应证差异很大。
- 该调查为描述性横断面网络调查,最终分析103家医院(30个州)的103份问卷。
适用人群与场景
- 美国参与成人快速反应系统的临床医生,由研究团队成员通过个人与专业联系在2018年6月至12月共7个月期间识别。
研究设计与关键结果
- 研究类型为描述性横断面网络调查,分发114份问卷,回收109份(96%),排除6份重复后最终分析103家医院(来自30个州)的103份问卷。
- 76%的医院为学术医院,30%为大型医院(>750张住院床位),58%拥有大型ICU(>50张ICU床位)。
- 快速反应系统传入支与传出支的结构和功能差异很大,多数医院设有快速反应团队和心脏骤停团队。
- 大多数快速反应团队包含一名提供者、一名重症监护护士和一名呼吸治疗师。
- 在有内科、麻醉科、急诊科或重症医学科培训项目的医院,45%的快速反应团队和75%的心脏骤停团队由受训人员主导,主治医师在场情况不一致。
- 院内心脏骤停后目标温度管理和冠状动脉导管插入术广泛使用,但适应证差异很大。
证据类型、等级与局限
- 证据类型为描述性横断面网络调查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论为快速反应系统的结构、功能以及院内心脏骤停期间和之后的管理存在很大差异;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Despite improvements in the management of in-hospital cardiac arrest over the past decade, in-hospital cardiac arrest continues to be associated with poor prognosis. This has led to the development of rapid response systems, hospital-wide efforts to improve patient outcomes by centering on prompt identification of decompensating patients, expert clinical management, and continuous quality improvement of processes of care. The rapid response system may include cardiac arrest teams, which are centered on identification and treatment of patients with in-hospital cardiac arrest. However, few evidence-based guidelines exist to guide the formation of such teams, and the degree of their variation across the United States has not been well described.
DESIGN: Descriptive cross-sectional, internet-based survey.
SETTING: Cohort of preidentified clinicians involved in their hospital's adult rapid response system across the United States.
SUBJECTS: Clinicians who had been identified by study team members using personal and professional contacts over a 7-month period from June 2018 to December 2018.
INTERVENTIONS: An 80-item survey was developed by the investigators. It sought information on the afferent (identification and notification of providers) and efferent (response of providers to patient) limbs of the rapid response system, as well as management of patients post in-hospital cardiac arrest.
MEASUREMENTS AND MAIN RESULTS: One-hundred fourteen surveys were distributed. Of these, 109 (96%) were completed. Six were duplicates and were excluded, leaving a total of 103 surveys from 103 hospitals in 30 states. Seventy-six percent of hospitals were academic, 30% were large hospitals (> 750 inpatient beds), and 58% had large ICUs (> 50 ICU beds). We found wide variation in the structure and function in both the afferent and efferent limbs of the rapid response system. The majority of hospitals had a rapid response team and a cardiac arrest team. Most rapid response teams contained a provider, a critical care nurse, and a respiratory therapist. In hospitals with training programs in internal medicine, anesthesia, emergency medicine, or critical care, 45% of rapid response teams and 75% of cardiac arrest teams were led by trainees, with inconsistent attending presence. Targeted temperature management and coronary catheterization were widely used post in-hospital cardiac arrest, but indications varied considerably.
CONCLUSIONS: We have demonstrated substantial variation in the structure and function of rapid response systems as well as in management of patients during and after in-hospital cardiac arrest.
参考来源
- Mitchell OJL, Motschwiller CW, Horowitz JM, et al. Rapid Response and Cardiac Arrest Teams: A Descriptive Analysis of 103 American Hospitals. Crit Care Explor. 2019. PMID: 32166272. doi:10.1097/CCE.0000000000000031
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。